These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34429646)

  • 1. A Randomized, Crossover, Adhesion Performance and Pharmacokinetic Study of a Lidocaine Topical System Under Conditions of Water Exposure in Healthy Subjects.
    Vought K; Greuber E; Patel K; Argoff C; Lissin D
    J Pain Res; 2021; 14():2459-2467. PubMed ID: 34429646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Crossover, Pharmacokinetic and Adhesion Performance Study of a Lidocaine Topical System 1.8% During Physical Activity and Heat Treatment in Healthy Subjects.
    Fudin J; Wegrzyn EL; Greuber E; Vought K; Patel K; Nalamachu S
    J Pain Res; 2020; 13():1359-1367. PubMed ID: 32606902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects.
    Gudin J; Webster LR; Greuber E; Vought K; Patel K; Kuritzky L
    J Pain Res; 2021; 14():513-526. PubMed ID: 33654425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-Label Adhesion Performance Study of a Prescription Lidocaine Topical System 1.8% versus Three Lidocaine-Containing Over-the-Counter Patches in Healthy Subjects.
    Fudin J; Vought K; Patel K; Lissin D; Maibach H
    J Pain Res; 2022; 15():2051-2065. PubMed ID: 35923843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects.
    Gudin J; Argoff C; Fudin J; Greuber E; Vought K; Patel K; Nalamachu S
    J Pain Res; 2020; 13():1485-1496. PubMed ID: 32606914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of application durations and heat on the pharmacokinetic properties of drug delivered by a lidocaine/tetracaine patch: a randomized, open-label, controlled study in healthy volunteers.
    Marriott TB; Charney MR; Stanworth S
    Clin Ther; 2012 Oct; 34(10):2174-83. PubMed ID: 22943969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference.
    Dmochowski RR; Newman DK; Sand PK; Rudy DC; Caramelli KE; Thomas H; Hoel G
    Clin Drug Investig; 2011; 31(8):559-571. PubMed ID: 21721591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biorelevant In Vitro Skin Permeation Testing and In Vivo Pharmacokinetic Characterization of Lidocaine from a Nonaqueous Drug-in-Matrix Topical System.
    Greuber E; Vought K; Patel K; Suzuki H; Usuda K; Shiramizu A; Koplowitz LP; Koplowitz B; Maibach HI; Lissin D
    AAPS PharmSciTech; 2021 Aug; 22(6):215. PubMed ID: 34386908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
    DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ
    Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of the Rate and Extent of Drug Released from Commercial Topical Delivery Systems During Wear: An Example with Lidocaine Topical Systems.
    Cai Q; Azarpanah A; Bhatt JA; Wei H; Carr J; Morris KR; Strasinger C; Brogden NK
    Pharm Res; 2024 Jan; 41(1):39-50. PubMed ID: 37848751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exercise.
    Archer DF; Stanczyk FZ; Rubin A; Foegh M
    Contraception; 2013 Feb; 87(2):212-9. PubMed ID: 23158806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Treatment of Topical Drugs for Postherpetic Neuralgia: A Network Meta-Analysis.
    Liu X; Wei L; Zeng Q; Lin K; Zhang J
    Pain Physician; 2020 Nov; 23(6):541-551. PubMed ID: 33185370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
    Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
    Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical lidocaine for the treatment of postherpetic neuralgia.
    Khaliq W; Alam S; Puri N
    Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of lidocaine as a topical analgesic and improvements in patch delivery systems.
    Gudin J; Nalamachu S
    Postgrad Med; 2020 Jan; 132(1):28-36. PubMed ID: 31900074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of anorectal nifedipine and lidocaine (lignocaine) ointment following haemorrhoidectomy: an open-label, single-dose, phase IV clinical study.
    Perrotti P; Dominici P; Grossi E; Antropoli C; Giannotti G; Cusato M; Regazzi M; Cerutti R
    Clin Drug Investig; 2009; 29(4):243-56. PubMed ID: 19301938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.
    Galer BS; Rowbotham MC; Perander J; Friedman E
    Pain; 1999 Apr; 80(3):533-538. PubMed ID: 10342414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical pain management with the 5% lidocaine medicated plaster--a review.
    Mick G; Correa-Illanes G
    Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
    Davies PS; Galer BS
    Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.